PRF Technologies Ltd. (PRFX): Total Assets
$12.00M
As of 2025-12-31
-0.9%
3-year compound annual growth
-7.6%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.00M | +165.1% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $4.53M | -54.4% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $9.93M | -19.5% | 2025-04-07, Balance as of period end |
| 2022-12-31 | $12.33M | -35.4% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $19.07M | +7.1% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $17.80M | n/m | 2022-03-16, Balance as of period end |
| 2019-12-31 | $1.16M | n/a | 2021-03-18, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $12.00M | +165.1% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $225.9K | -13.7% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $127.6K | -19.4% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $29.72M | +63.0% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $17.41M | -14.2% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $340.05M | -30.7% |
| Genelux Corp (GNLX) | 2025-12-31 | $19.03M | -45.2% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
Compare PRFX, BDPT, SKVI, JUNS side by side · Screen every company in Pharmaceutical Preparations ↗